| 1 | Journal of the National Cancer Center | 25.2 | JCR Q1 |
| 2 | Journal of the National Comprehensive Cancer Network | 17.5 | JCR Q1Top |
| 3 | BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER | 11.2 | JCR Q1Top |
| 4 | BIODRUGS | 8.5 | JCR Q1 |
| 5 | Molecular Therapy Oncology | 8.5 | JCR Q1 |
| 6 | npj Breast Cancer | 8.4 | JCR Q1 |
| 7 | Clinical and Translational Medicine | 7.9 | JCR Q1Top |
| 8 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 7.4 | JCR Q1Top |
| 9 | INTERNATIONAL JOURNAL OF ONCOLOGY | 7.3 | JCR Q1 |
| 10 | Radiology-Imaging Cancer | 7.2 | JCR Q1 |
| 11 | Cancer Cell International | 7 | JCR Q1Top |
| 12 | MOLECULAR CANCER THERAPEUTICS | 6.9 | JCR Q1Top |
| 13 | PROSTATE CANCER AND PROSTATIC DISEASES | 6.9 | JCR Q1 |
| 14 | BREAST CANCER RESEARCH | 6.2 | JCR Q1 |
| 15 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 6.2 | JCR Q1Top |
| 16 | OncoImmunology | 6.2 | JCR Q1Top |
| 17 | Gastric Cancer | 6.1 | JCR Q1 |
| 18 | Oncogenesis | 6 | JCR Q1 |
| 19 | Cancer & Metabolism | 5.9 | JCR Q1 |
| 20 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 5.8 | JCR Q1 |
| 21 | CURRENT TREATMENT OPTIONS IN ONCOLOGY | 5.8 | JCR Q1Top |
| 22 | MOLECULAR CANCER RESEARCH | 5.8 | JCR Q1 |
| 23 | RADIOTHERAPY AND ONCOLOGY | 5.8 | JCR Q1Top |
| 24 | CANCER BIOLOGY & THERAPY | 5.7 | JCR Q1 |
| 25 | Clinical Epigenetics | 5.7 | JCR Q1Top |
| 26 | CANCER | 5.6 | JCR Q1Top |
| 27 | CELLULAR ONCOLOGY | 5.6 | JCR Q1 |
| 28 | Annual Review of Cancer Biology | 5.5 | JCR Q1 |
| 29 | JCO Oncology Practice | 5.5 | JCR Q1 |
| 30 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 5.4 | JCR Q1 |
| 31 | JOURNAL OF PATHOLOGY | 5.4 | JCR Q1Top |
| 32 | LUNG CANCER | 5.3 | JCR Q1 |
| 33 | BREAST | 5.2 | JCR Q1Top |
| 34 | Current Oncology Reports | 5.2 | JCR Q1Top |
| 35 | BONE MARROW TRANSPLANTATION | 5.1 | JCR Q1 |
| 36 | Targeted Oncology | 5.1 | JCR Q1 |
| 37 | CANCER SCIENCE | 4.9 | JCR Q2 |
| 38 | INTERNATIONAL JOURNAL OF CANCER | 4.9 | JCR Q2Top |
| 39 | CANCER IMAGING | 4.8 | JCR Q1 |
| 40 | Cancers | 4.8 | JCR Q2 |
| 41 | JNCI Cancer Spectrum | 4.8 | JCR Q2 |
| 42 | NEOPLASIA | 4.8 | JCR Q2 |
| 43 | JCO Precision Oncology | 4.7 | JCR Q2Top |
| 44 | ONCOLOGIST | 4.7 | JCR Q2Top |
| 45 | ONCOLOGY RESEARCH | 4.6 | JCR Q2 |
| 46 | Gynecologic Oncology | 4.5 | JCR Q1 |
| 47 | Molecular Oncology | 4.5 | JCR Q2 |
| 48 | ENDOCRINE-RELATED CANCER | 4.4 | JCR Q2 |
| 49 | Journal of Gynecologic Oncology | 4.2 | JCR Q1 |
| 50 | BMC CANCER | 4.1 | JCR Q2 |
| 51 | Therapeutic Advances in Medical Oncology | 4.1 | JCR Q2 |
| 52 | PSYCHO-ONCOLOGY | 3.9 | JCR Q1Top |
| 53 | JTO Clinical and Research Reports | 3.6 | JCR Q2 |
| 54 | Radiation Oncology | 3.6 | JCR Q1 |
| 55 | EXPERIMENTAL CELL RESEARCH | 3.5 | JCR Q2 |
| 56 | Journal of Cancer Survivorship | 3.4 | JCR Q1 |
| 57 | SUPPORTIVE CARE IN CANCER | 3.4 | JCR Q1 |
| 58 | CANCER CYTOPATHOLOGY | 2.9 | JCR Q2 |